Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids

Biomed Chromatogr. 2009 Aug;23(8):843-51. doi: 10.1002/bmc.1194.

Abstract

A method was developed and validated to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids by high-performance liquid chromatography with UV detection after derivatization with o-phenylenediamine. The advantages of this method compared with direct HPLC analysis are (i) the possibility of quantifying 3,4-dideoxyglucosone-3-ene simultaneously together with other glucose degradation products, (ii) the compatibility of the method with MS detection for unequivocal identification of the analyte and (iii) a bathochromic shift of the UV absorbance maximum which leads to higher selectivity. The validated method was used to measure 3,4-dideoxyglucosone-3-ene concentrations additionally to the glucose degradation products 3-deoxyglucosone, methylglyoxal, glyoxal, 5-hydroxymethylfurfural, 2-furaldehyde, formaldehyde and acetaldehyde in 19 commercial products for peritoneal dialysis.

Publication types

  • Validation Study

MeSH terms

  • Chromatography, High Pressure Liquid / methods*
  • Dialysis Solutions / analysis*
  • Glucose / analysis*
  • Glucose / metabolism*
  • Humans
  • Linear Models
  • Peritoneal Dialysis
  • Phenylenediamines
  • Pyrones / analysis*
  • Sensitivity and Specificity

Substances

  • 3,4-dideoxyglucosone-3-ene
  • Dialysis Solutions
  • Phenylenediamines
  • Pyrones
  • 1,2-diaminobenzene
  • Glucose